Introduction
Apoptosis or programmed cell death is a process by which developmental or environmental stimuli activate a genetic program to implement a series of events that culminate in cell death (reviewed in Dragovich et al., 1998) . During our analysis of genes that are induced during the apoptotic death of myeloid precursor cells we identi®ed a novel gene, termed AATYK (Apoptosis Associated Tyrosine Kinase), whose expression is dramatically upregulated during the apoptotic death of myeloid cells induced by cytokine withdrawal.
An interesting aspect of this novel gene was that it encoded a 200 kDa protein with a putative tyrosine kinase domain at the N-terminus. In addition, the Cterminus contained 16 PXXP motifs that constitute the minimal SH3 binding motif, suggesting that AATYK might form signaling complexes with other SH3-domain-containing proteins. Northern blot analysis demonstrated that AATYK expression was highest in the brain, with lower levels of expression observed in the heart, lung, skeletal muscle and kidney. More importantly, the hybridization pattern using RNAs derived from these tissues suggested that AATYK encodes multiple transcripts which could be derived from alternative splicing that generates doublets of 5.5 and 5.1 kb in most tissues except liver.
In this communication, we have examined the nature of the alternatively spliced transcripts that are expressed in the brain and have identi®ed a novel transcript that encodes an additional exon that is not present in transcripts that were originally isolated from myeloid precursor cells. We have also examined the expression of AATYK in the adult brain and in P19 embryonal carcinoma cells to examine its role during neuronal development. These studies revealed that the AATYK protein is expressed throughout the brain and that its expression is up-regulated as a function of neuronal dierentiation.
Results

Identification of an alternatively spliced AATYK transcript
Our previous studies have shown that multiple transcripts hybridize to a full-length AATYK probe in Northern blots containing mRNA derived from adult mouse brain, but not in those blots containing RNA isolated from the 32Dcl3 myeloblastic cell line treated with granulocyte-colony stimulating factor (G-CSF) (Gaozza et al., 1997) . To determine the nature of the alternatively spliced transcripts, we screened human and mouse brain cDNA libraries for the presence of cDNAs that speci®cally hybridize with the 5' end of the mouse cDNA probe, described previously by us. This resulted in the isolation of a human cDNA fragment that contained an additional stretch of in-frame coding sequence that was located 5' to the translation start site of our mouse myeloid cDNA clone (Gaozza et al., 1997) . To determine whether this sequence was also expressed in the mouse brain and mouse myeloid cells, we performed an RT ± PCR reaction using a 5' (sense) primer that was derived from the beginning of this novel sequence and a 3' (antisense) primer that was derived from the coding sequence of the 32Dcl3-derived AATYK cDNA. The results of this experiment are presented in Figure 1 . Lane 1 shows the speci®c ampli®cation of a 164 bp band, which corresponds to the predicted size of the PCR fragment. When brain RNA was used as a template, this amplicon readily hybridized to an internal, novel sequence-derived oligonucleotide probe in Southern blot analysis (data not shown). No ampli®cation was observed in the 32Dcl3 RNA sample (lane 2), and additional 5' RACE experiments using this RNA failed to reveal any additional upstream sequences (data not shown). These results suggest that this exon is expressed in brainderived RNA but not in that derived from 32Dcl3 cells.
To further con®rm that this novel coding sequence is encoded by a separate exon, we screened a mouse genomic DNA library and isolated a 4.3 kb genomic clone that contained a 54 base pair stretch of DNA which was identical to the novel coding sequence found in the partial human brain cDNA (Figure 2 , our unpublished results). More importantly, the 5' and 3' sequences that immediately¯ank this region in the genomic clone contain the consensus splice donor and acceptor sequences (data not shown). Taken together, these results suggest that this region of DNA represents a novel exon which is transcribed in the brain. The sequence of this exon and the schematic representation of the 5' end of the alternatively spliced message, termed B-AATYK, are shown in Figure 2 .
The alternatively spliced RNA of AATYK codes for a larger protein
To demonstrate that the brain-speci®c mRNA codes for a protein which is larger than that encoded by 32Dcl3 cell RNA, we constructed a full-length B-AATYK cDNA by performing fusion PCR using our AATYK genomic and 32Dcl3-derived cDNA clones as templates. The resulting fragment, containing the entire B-AATYK open reading frame, was sub-cloned into the pBluescriptKS vector (Stratagene) and used as a template for T7-primed TNT (Promega) coupled in vitro transcription and translation. The major translation product, when analysed by SDS ± PAGE, migrated as a 210 kD band that was slightly larger than the myeloid AATYK protein (Figure 3a) . We next generated a 32Dcl3 cell line using the LacSwitch system (Stratagene) which places B-AATYK under the control of an IPTG-inducible promoter. The results of this experiment, presented in Figure 3b , also show that the B-AATYK protein migrates slower than AATYK in SDS ± PAGE, further supporting the in vitro translation data.
AATYK is expressed throughout the adult brain
Northern blot analyses have previously shown that AATYK expression at the RNA level is highest in the brain (Gaozza et al., 1997) . To speci®cally determine the regions of the brain in which the protein is expressed, we prepared protein extracts from speci®c regions of an adult rat brain and subjected them to Western blot analysis. The results of this experiment, presented in Figure 4 , show that the AATYK protein is expressed in all regions of the brain examined, including olfactory bulb, forebrain, cortex, midbrain, cerebellum and pons. Expression was also observed in the hindbrain (lane 7), albeit to a much lesser extent.
We next performed immunohistochemistry on cryosections of brains dervied from adult Sprague Dawley rats. Although AATYK-like immunoreactivity was detected at low levels throughout the entire brain, the most intense immunolabeling was observed within the cerebellum and olfactory bulb ( Figure 5a ). Speci®cally, AATYK expression was extremely pronounced within the main and accessory olfactory bulbs (Figure 5b, c, d) , where immunoreactivity was localized to glomeruli. These structures represent the sites of integration of signals between olfactory receptor neurons and second order sensory neurons (Mombaerts, 1999) . Immunohistochemical staining within the cerebellar cortex localized the AATYK protein to the granular layer and to distinct cellular processes, presumed to represent the radial ®bers of Bergmann 
AATYK expression is up-regulated during retinoic acidinduced differentiation of P19 embryonal carcinoma cells
Because the majority of AATYK expression in the brain was detected in mature neurons, it was of interest to determine if AATYK expression is regulated as a function of neuronal dierentiation. We therefore subjected the P19 embryonal carcinoma cell line to retinoic acid (RA) for various periods of time. Under these conditions, this cell line underwent programmed terminal dierentiation along the neuronal pathway, resulting in the accumulation of neuronal cells with neurite outgrowths and extended Figure 2 Genomic structure of the 5' end of AATYK locus and the cDNA sequence of the alternatively spliced transcript cloned from brain RNA. The upper diagram shows the structure of the 5' end of AATYK locus with its three 5' exons. The alternatively spliced mRNA that is expressed in the brain contains sequences derived from exon 1, which are spliced in frame to the sequences encoded by exon 2. On the other hand, the mRNAs derived from 32Dcl3 cells appear to lack any of the sequences derived from exon 1, but contain all of the sequences derived from exon 2 2) , the parental construct (lanes 3 and 4) and the B-AATYK construct (lanes 5 and 6) were separated by 6% SDS ± PAGE and analysed by Western blot analysis. Exogenous protein expression was induced for 24 h following exposure to 5 mM IPTG (lanes 2, 4 and 6) processes in a period of 9 days (Jones- Villeneuve et al., 1982) . Western blot analysis of protein extracted from these cells grown in the presence of RA for 0, 1, 3, 5, 7 and 9 days is shown in Figure 6a . Although AATYK expression was undetectable in the samples derived from cells at the early stages of dierentiation, high levels of AATYK expression are observed at days 7 and 9, a period of time at which the cells have dierentiated into neurons.
To determine if the protein is catalytically active, immunoprecipitates derived from these cells were subjected to in vitro kinase reactions. Figure 6b shows the auto-phosphorylation pro®le of AATYK in P19 cells treated with RA. Auto-phosphorylated AATYK was detected in samples derived from cells that have reached the 7th and 9th days of the dierentiation program, a result which parallels that obtained in the Western blot analysis (Figure 6a ). Taken together, the results presented in Figure 6 demonstrate that the AATYK protein, which is induced during RA-induced neuronal dierentiation, is an active kinase.
Discussion
The AATYK (Apoptosis Associated Tyrosine Kinase) gene was originally identi®ed as a novel gene which encodes a dierentially expressed mRNA which is upregulated during the apoptotic death of myeloid cells induced by cytokine deprivation. The results presented in this communication show that the AATYK gene also codes for an alternatively spliced mRNA, termed B-AATYK, which is 18 amino acids longer than the form which was originally described by us (Gaozza et al., 1997) . The proteins encoded by both AATYK and B-AATYK have several distinctive features that are not present in any other tyrosine kinases that have been described in literature thus far. These include the presence of the tyrosine kinase domain at the N-terminus of the molecule and the appearance of 16 putative SH3 binding motifs at the C-terminal end. It is interesting to note that myeloid cells appear to express only one of the alternatively spliced forms, whereas the brain expresses both forms as judged by the appearance of a doublet in the Northern blots and RT ± PCR analysis (data not shown). Although the signi®cance and function of these two alternatively spliced forms remain to be determined, it is important to note that among all of the tissues in which AATYK is expressed, the highest mRNA levels are present in the brain. In this context, it is also important to note that programmed cell death plays an important role in nueronal development as evidenced by the fact that approximately 50% of the neurons undergo apoptosis during development (Gordon, 1995; Narayanan, 1997) . To gain an understanding of its role in the brain, we performed immunohistochemical studies aimed at localizing the AATYK protein in adult rat brain. These studies show that AATYK immunoreactivity was detected at low levels throughout the entire brain, with the highest levels of immunolabeling being detected within the cerebellum and olfactory bulb ( Figure 5 ). In the cerebellum, AATYK expression was distinctly associated with the radial processes of Bergmann glial cells, which extended through the molecular layer (ml) of the cerebellar cortex to the pial surface. During early cerebellar development, Bergmann glial cells are thought to be crucial for the ordered layering that occurs in the cortex. While the role that these cells play in the adult brain is not well understood, these processes are thought to form the`scaold' upon which granule neurons migrate into their ®nal position. Although labeling was also observed in the granular layer, it was not detected in cerebellar white matter, indicating that expression was restricted to the cerebellar cortex (Palay and Chan-Palay, 1974; Altman, 1975) . These results suggest that AATYK is normally expressed in adult brain and is not necessarily always associated with apoptotic death of the neurons. In fact, previous studies by Raghunath et al. (2000) have shown that ectopic AATYK expression was able to promote the dierentiation of SH-SY5Y adrenergic neuroblastoma cells without eecting their survival.
AATYK expression was also extremely pronounced within the main and accessory regions of the olfactory bulb ( Figure 5) . Here, the densest immunolabeling was found in the olfactory glomeruli. These structures are composed of the aerent terminals of olfactory receptors located in the peripheral olfactory epithelium and vomeronasal Figure 4 Western blot analysis of AATYK expression in the adult rat brain. Protein lysates derived from the indicated regions of an adult rat brain were separated by 8% SDS ± PAGE and subjected to Western blot analysis using an AATYK-speci®c antiserum organ and the dendritic processes of their synaptic targets in the olfactory bulb. However, we did not observed AATYK immunolabeling of second order sensory neurons in any region of the olfactory bulb, and therefore presume that primary olfactory receptors express the AATYK protein. It is of interest to note that the olfactory system retains the ability to regenerate itself (Halpern, 1987) . Because high levels of AATYK expression have also been detected in the liver, another organ that is capable of regeneration, it is possible that AATYK may also play a role in these regeneration pathways.
In the myeloid cell system, it was observed that AATYK expression is up-regulated not only under conditions of cytokine deprivation, but also during GCSF-induced terminal dierentiation of myeloblasts to granulocytes. Because the majority of AATYK expression in the brain was detected in mature neurons, it was of interest to determine if AATYK expression is regulated as a function of neuronal dierentiation. To determine this, we utilized the P19 embryonal carcinoma cell system which can be induced to terminally dierentiate into neurons with neurite outgrowths and extended processes by incubation in RA-containing medium (Jones-Villeneuve et al., 1982) . Western blot analysis of protein extracted from these cells grown in the presence of RA showed that AATYK expression was undetectable in cells at the early stages of dierentiation, while terminally dierentiated cells expressed high levels of the protein.
These results are consistent with earlier studies that used a neuroblastoma cell line (Raghunath et al., 2000) and suggest that the AATYK protein is upregulated during RA-induced terminal dierentiation of neuronal cells. In addition, this increase in AATYK expression is remarkably similar to that reported by us ,d) . In both regions, the immunohistochemical staining was distinctly localized to the glomeruli (gl) and the neurophil of the external plexiform layer (epl). (e) AATYK immunolabeling in the cerebellum. At low magni®cation, the immunoreaction products are distributed to the molecular (ml) and granular (gr) layers, but not white matter (wm). (f) However, at higher magni®cation, staining is observed within the radial ®bers of the Bergmann glial cells in the molecular layer. Arrows show staining of the Bergmann glial processes for myeloid precursor cells subjected to undergo terminal dierentiation into granulocytes in the presence of G-CSF (Gaozza et al., 1997) . To determine if AATYK expressed in neurons is catalytically active, we have examined the tyrosine kinase activity of AATYK protein expressed in P19 cells treated with retinoic acid. These results, shown in Figure 6 , suggest that auto-phosphorylated AATYK can be detected in samples derived from cells that have reached the 7th and 9th days of the dierentiation program, a result which parallels that obtained in the Western blot analysis. Taken together, these results suggest that the AATYK protein is induced during RA-induced neuronal dierentiation in a catalytical form.
The data presented in this manuscript suggest that AATYK may play a role in the terminal dierentiation of neurons and participate in programmed cell death of some of these terminally dierentiated cells. It is unclear whether the two alternatively spliced mRNAs code for two distinctive proteins that are individually associated with dierent functions such as terminal dierentiation and apoptosis. If this were to be the case, it is possible that the N-terminal domain of the two proteins may contain motifs that speci®cally interact with cellular proteins that regulate AATYK function under dierent physiological conditions. It is also possible that one set of conditions may lead to cell death while another set of conditions may lead to terminal dierentiation. A detailed understanding of the nature of proteins that interact with AATYK, and their eect on AATYK function may shed further light on neuronal growth, dierentiation and programmed cell death.
Materials and methods
Cell culture
P19 embryonal carcinoma cells were maintained in Dulbecco's Modi®ed Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), penicillin-streptomycin under humidi®ed conditions and 5% CO 2 . For retinoic acid-induced dierentiation, actively growing cells were plated in nontreated tissue culture dishes in the presence of serum-free medium containing 1.0 mM retinoic acid for a period of 72 h. The cells were then washed and re-plated in treated dishes in the presence of serum supplemented medium containing 10 mg/ml arabinose.
RNA preparation and RT ± PCR analysis
Total RNA from 32Dcl3 cells and mouse brain was prepared as previously described (Chomczynski and Sacchi, 1987) . One mg of each sample was subjected to random hexamer and oligo-dT-primed reverse transcription according to the instructions of the enzyme's manufacturer (Life Technologies). The reverse transcribed cDNAs were then used as templates in a standard PCR reaction with AATYK-speci®c primers. The sequence of the primers used to amplify the brain-speci®c sequences are as follows: primer B1, 5'-ATG TCG TCG TCC TTC TTC AA-3' and primer B2, 5'-CAA CAC AGG CAG GCC AGC AT-3'.
In vitro transcription-translation
In vitro transcription-translation was performed using the T7-coupled TNT kit (Promega) supplemented with [
S]Express
Protein Labeling Mixture (NEN, DuPont) as described by the manufacturer. Labeled translation products were analysed on 6% SDS ± PAGE according to Lammeli (1970) and the resulting gel ®xed, enhanced, dried and subjected to autoradiography.
Immunohistochemistry
Two 1-year-old, anaesthetized Sprague-Dawley rats were perfused through the ascending aorta with a vascular rinse at room temperature (0.9% NaCl), followed by 500 cc of a ®xative solution (4% formaldehyde/0.5% zinc-dichromate/ 0.125% glutaraldehyde/0.75% NaCl, pH 4.8) as previously described (Berrebi and Spirou, 1998) . Brains were left undisturbed for 1 h prior to the dissection of the cranium. Whole brains were cryoprotected overnight in 30% sucrose/ saline and frozen parasagittal sections (30 mm thickness) were collected in series order on a sliding microtome and rinsed in 0.5 M Tris-Cl, pH 7.6. The free-¯oating sections were immuno-reacted in Netwell dishes (Costar). Slices were ®rst incubated in 5% normal donkey serum (NDS) with 0.5% Triton X-100 in 0.5 M Tris-Cl for 1 h at room temperature. The tissues were subsequently immersed for 48 h (with continuous gentle agitation) in anity absorbed rabbit AATYK antiserum (1 mg/ml) combined with 0.5% NDS and 0.1% Triton X-100 in 0.5 M Tris, Cl. All sections were then incubated for 1 h in goat anti-rabbit IgG serum (1 : 100) and then in rabbit anti-PAP (1 : 100; Sternberger Monoclonals). Bound antigen was detected by immersing the Figure 6 Induction of AATYK expression during RA-induced neuronal dierentiation of P19 cells. (a) Protein was isolated at days 0, 1, 3, 5, 7 and 9 from P19 cells induced to dierentiate along the neuronal pathway and subjected to Western blot analysis using an AATYK-speci®c antiserum. (b) The same antibody was used to perform an in vitro kinase assay. Autophosphorylated AATYK protein is shown sections in 0.05% diaminobenzidine and 0.01% H 2 O 2 , pH 7.6 for 10 min. Each incubation was followed by washes using 0.5 M Tris-Cl. Control sections that were incubated in matched rabbit pre-immune serum and processed in parallel with the experimental sections were free of immunoreaction product (data not shown). Sections were mounted on gelatinalcohol pre-treated glass slides and coverslipped with Accumount (Baxter). Whole parasagittal sections were placed in a Durst enlarger and negative images were produced on multi-contrast photographic paper. High magni®cation micrographs of olfactory and cerebellar tissues were generated from digital images produced by an Optronics Magna®re digital camera attached to an Olympus AX-70 microscope.
Generation of 32D/B-AATYK cells
B-AATYK inducible cells were generated using the LacSwitch system (Stratagene). The full-length B-AATYK cDNA was sub-cloned into the pOPRSVI expression vector. Ten mg of the expression and p3'SS repressor plasmids were simultaneously introduced into 32Dcl3 cells by electroporation at 300 volts and a resistance of 960 mFaradays. Transfected cells were selected in 1 mg/ml hygromycin (Calbiochem) and 500 mg/ml G418 (Life Technologies).
Western blot analysis
Whole cell lysates were derived from P19 cells using RIPA buer supplemented with protease and phosphatase inhibitors (150 mM NaCl/50 mM Tris-Cl, pH 7.5/1% NP-40/0.1% sodium deoxycholate/1 mM EDTA/2 mM EGTA/2 mM aprotinin/2 mM PMSF/2 mM leupeptin/2 mM pepstatin/2 mM NaF/2 mM Na 3 VO 4 ). An adult brain isolated from a 1-year-old rat was dissected and the sections homogenized using a glass homogenizer in the presence of RIPA buer containing protease inhibitors (as described above) in the absence of SDS. One hundred and ®fty mg of total lysate were resolved by SDS ± PAGE, transferred to nitrocellulose membranes and probed with an AATYK-speci®c polyclonal antiserum (Gaozza et al., 1997) . Proteins were visualized using Enhanced Chemiluminescence (NEN, DuPont).
In vitro kinase assay P19 cells were lysed in 1.0% NP40/PBS and 1 mg of total cell lysate was subjected to immunoprecipitation using an AATYK speci®c antibody for 1 h at 48C. The resulting immune complexes were precipitated using 50 ml protein A sepharose (50% slurry) and the beads washed twice in lysis buer and once in kinase reaction buer (50 mM PIPES, pH 7.0/10 mM MnCl 2 /10 mM DTT) (Chang et al., 1998) . Thirty ml of kinase reaction buer supplemented with 20 mM ATP and 5 mCi of g-32 P-ATP was added to each sample and incubated for 20 min at 308C. In vitro phosphorylated proteins were separated by 6% SDS ± PAGE according to Lammeli (1970) . The resulting gel was ®xed overnight in ®xative solution (10% glacial acetic acid/30% methanol), dried, and the phosphorylated proteins visualized by phosphorimager analysis (Fuji).
